Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...
Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says ...
The emerging prevalence of digitalization is a key topic for manufacturers handling excipients. Digital transformation and data integrity protocols are crucial strategies for optimizing drug ...
FSSAI orders removal of non-compliant drinks falsely labelled as “ORS”, targeting deceptive marketing and protecting ...
United Therapeutics' stock surged after IPF trial results and what future pivotal trials could mean for investors. See here ...
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the ...
Stockhead on MSN
Biocurious: Inhalerx hones in on pot for pain and panic in its quest for historic drug approval
Minnow Inhalerx hopes to be first to market with inhaled synthetic medical cannabis therapies for cancer pain and panic ...
The approval puts Lunsumio on the same footing as Epkinly (epcoritamab) in FL – a form of non-Hodgkin lymphoma (NHL) – as ...
Cash and cash equivalents totaled €119.0 million as of September 30, 2025€39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Rafa Laboratories secured a BARDA contract to develop an intramuscular TXA injection for prehospital bleeding care.
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback